Contributed By Walder Wyss Ltd
Advertising of medicines on the internet without any access restriction is considered to be advertising to the public (cf. Article 15 lit. c AWV). Therefore, the rules applicable to advertising to the public apply.
If articles and contributions from other media about a company or its medicines are offered on the website of that company (press reviews), the content of these articles and contributions are attributed to that company in terms of advertising law. Therefore, the provisions of the AWV are fully applicable to such press reviews (Swissmedic Journal 8/2006, p. 796 et seqq.).